CNET on MSN18h
Novavax Is Here for the COVID Fight: What to Know About the Vaccine
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...
Novavax: Lack Of Sustainable Revenue Growth Is A Problem
Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi. Find out why I remain ...
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last?
Novavax (NVAX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
Is one COVID vaccine better than the others? An infectious disease doctor breaks it down
Which COVID vaccine is better of the Pfizer, Modern and Novavax options? Here's how they compare with safety and efficacy and ...
Novavax cools after clarifying analyst report on COVID vaccine market
Novavax (NVAX) stock fell after a clarification on an analyst report led to a sharp rally in the company stock in the ...
CNET5d
Make Room, mRNA: What to Know About the Novavax COVID Vaccine
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
Canada not ordering Novavax protein-based COVID vaccine this year due to low demand
TORONTO — The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus ...
The Canadian Press on MSN2d
‘I have no options’: Canadians criticize lack of Novavax COVID shot
The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say.
bovnews1d
Novavax Inc (NVAX) Stock: Surpassing Expectations in the Market?
On Thursday, Novavax Inc (NVAX) stock saw a decline, ending the day at $14.42 which represents a decrease of $-0.26 or -1.77% from the prior close of $14.68. The stock opened at $14.07 and touched a ...